| Lorrie Michelle Belnap, LCSW | |
|
154 E Myrtle Ave Ste 204, Murray, UT 84107-4850 | |
| (801) 369-8989 | |
| (801) 704-9741 |
| Full Name | Lorrie Michelle Belnap |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 154 E Myrtle Ave Ste 204, Murray, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093006348 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 293589-3501 (Utah) | Primary |
| Entity Name | Ascendant Behavioral Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689128605 PECOS PAC ID: 1850673187 Enrollment ID: O20170123001085 |
News Archive
High levels of high-density lipoprotein cholesterol inhibit the formation of abdominal aortic aneurysm, findings from experimental mouse models suggest.
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.
Poor sleep doubles hospitalisations in heart failure, according to new research in nearly 500 patients presented today at EuroHeartCare 2014.
Using a mouse model, scientists from the RIKEN-Max Planck Joint Research Center for Systems Chemical Biology and a number of other institutes have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD).
The cell is understood to be highly organized, with specialized areas for different functions and molecular motors shuttling components around.
› Verified 5 days ago
| Entity Name | Cedar Psychiatry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265092282 PECOS PAC ID: 2163750688 Enrollment ID: O20190822000230 |
News Archive
High levels of high-density lipoprotein cholesterol inhibit the formation of abdominal aortic aneurysm, findings from experimental mouse models suggest.
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.
Poor sleep doubles hospitalisations in heart failure, according to new research in nearly 500 patients presented today at EuroHeartCare 2014.
Using a mouse model, scientists from the RIKEN-Max Planck Joint Research Center for Systems Chemical Biology and a number of other institutes have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD).
The cell is understood to be highly organized, with specialized areas for different functions and molecular motors shuttling components around.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lorrie Michelle Belnap, LCSW 154 E Myrtle Ave Ste 204, Murray, UT 84107-4850 Ph: (801) 369-8989 | Lorrie Michelle Belnap, LCSW 154 E Myrtle Ave Ste 204, Murray, UT 84107-4850 Ph: (801) 369-8989 |
News Archive
High levels of high-density lipoprotein cholesterol inhibit the formation of abdominal aortic aneurysm, findings from experimental mouse models suggest.
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.
Poor sleep doubles hospitalisations in heart failure, according to new research in nearly 500 patients presented today at EuroHeartCare 2014.
Using a mouse model, scientists from the RIKEN-Max Planck Joint Research Center for Systems Chemical Biology and a number of other institutes have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD).
The cell is understood to be highly organized, with specialized areas for different functions and molecular motors shuttling components around.
› Verified 5 days ago
Mr. James Matthew Upton, LCSW, BCBA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4444 S 700 E Ste 203, Murray, UT 84107 Phone: 801-268-4887 | |
Shane D Adamson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 525 E 4500 S, F-200, Murray, UT 84107 Phone: 801-747-2300 | |
Nancy M Hogarty Baker, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5250 So Commerce Dr, Ste 250, Murray, UT 84107 Phone: 801-261-3500 Fax: 801-261-2111 | |
Sevon Taroian, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 154 E Myrtle Ave Ste 204, Murray, UT 84107 Phone: 801-369-8989 Fax: 801-704-9741 | |
Malisa May Lemon, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5284 S Commerce Dr Ste C134, Murray, UT 84107 Phone: 801-266-4643 | |
Sloane Rampton, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4848 S Commerce Dr, Murray, UT 84107 Phone: 385-232-3484 | |
Mary Elizabeth Andolsek, LCSW,CT Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5411 S Vine St # 6, Murray, UT 84107 Phone: 801-783-8401 |